Trimipramine

DRUG3 trials

Sponsors

HolsboerMaschmeyer NeuroChemie GmbH, Hannover Medical School, Centre Hospitalier Universitaire Vaudois

Conditions

Anxiety DisordersDementiaDepressionGlioblastomaMajor DepressionPsychosomatic DisordersRecurrence TumorSchizophrenia

Phase 2

Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial

RecruitingNCT07263438

Centre Hospitalier Universitaire VaudoisGlioblastoma, Recurrence Tumor

Start: 2025-11-03End: 2030-12-31Target: 59Updated: 2026-02-13

Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

TerminatedNCT02374567

Hannover Medical SchoolAnxiety Disorders, Dementia, Depression +2

Start: 2015-01-31End: 2017-06-28Updated: 2018-02-28

Phase 4

Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene

HolsboerMaschmeyer NeuroChemie GmbHMajor Depression

Start: 2011-09-30End: 2014-12-31Target: 80Updated: 2014-09-12